Inspire Medical Systems Stock Debt To Equity

INSP Stock

USD 192.76 1.24 0.64%

Inspire Medical Systems fundamentals help investors to digest information that contributes to Inspire Medical's financial success or failures. It also enables traders to predict the movement of Inspire Stock. The fundamental analysis module provides a way to measure Inspire Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inspire Medical stock.

		Last Reported	Projected for Next Year
	Debt To Equity	0.04	0.04

As of 12/01/2024, Debt To Equity is likely to drop to 0.04.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Inspire Medical Systems Company Debt To Equity Analysis

Inspire Medical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Inspire Medical Debt To Equity

0.14 %

Most of Inspire Medical's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inspire Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Inspire Debt To Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Inspire Medical is extremely important. It helps to project a fair market value of Inspire Stock properly, considering its historical fundamentals such as Debt To Equity. Since Inspire Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Inspire Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Inspire Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Invested Capital	Net Working Capital	Capital Stock	Accumulated Depreciation	Current Deferred Revenue	Long Term Investments
Total Assets		1.0	0.99	-0.8	-0.98	0.97	0.51	0.98	0.51	1.0	0.9	0.54	1.0	-0.31	0.82	0.94	0.93	0.93	0.96	0.74	0.74	-0.15
Total Stockholder Equity	1.0		0.99	-0.81	-0.97	0.97	0.51	0.98	0.51	0.99	0.9	0.53	1.0	-0.32	0.82	0.94	0.94	0.94	0.96	0.73	0.73	-0.17
Net Tangible Assets	0.99	0.99		-0.82	-0.97	0.93	0.57	0.95	0.57	1.0	0.91	0.54	1.0	-0.34	0.87	0.93	0.95	0.95	0.95	0.69	0.69	-0.18
Net Debt	-0.8	-0.81	-0.82		0.83	-0.71	-0.31	-0.73	-0.31	-0.82	-0.75	-0.42	-0.82	0.18	-0.75	-0.8	-0.86	-0.87	-0.84	-0.28	-0.28	0.47
Retained Earnings	-0.98	-0.97	-0.97	0.83		-0.93	-0.48	-0.96	-0.48	-0.99	-0.92	-0.57	-0.98	0.19	-0.86	-0.97	-0.93	-0.92	-0.98	-0.66	-0.66	0.15
Accounts Payable	0.97	0.97	0.93	-0.71	-0.93		0.34	1.0	0.34	0.94	0.84	0.48	0.96	-0.26	0.68	0.94	0.86	0.86	0.93	0.83	0.83	-0.05
Long Term Debt	0.51	0.51	0.57	-0.31	-0.48	0.34		0.37	1.0	0.55	0.45	0.63	0.52	-0.21	0.78	0.3	0.48	0.5	0.4	0.22	0.22	-0.26
Net Receivables	0.98	0.98	0.95	-0.73	-0.96	1.0	0.37		0.37	0.96	0.87	0.49	0.97	-0.26	0.72	0.96	0.88	0.88	0.96	0.81	0.81	-0.06
Long Term Debt Total	0.51	0.51	0.57	-0.31	-0.48	0.34	1.0	0.37		0.55	0.45	0.63	0.52	-0.21	0.78	0.3	0.48	0.5	0.4	0.22	0.22	-0.26
Capital Surpluse	1.0	0.99	1.0	-0.82	-0.99	0.94	0.55	0.96	0.55		0.91	0.55	1.0	-0.31	0.86	0.94	0.94	0.94	0.97	0.7	0.7	-0.16
Total Liab	0.9	0.9	0.91	-0.75	-0.92	0.84	0.45	0.87	0.45	0.91		0.54	0.9	-0.18	0.86	0.89	0.97	0.96	0.92	0.73	0.73	0.01
Short Long Term Debt	0.54	0.53	0.54	-0.42	-0.57	0.48	0.63	0.49	0.63	0.55	0.54		0.54	0.46	0.75	0.48	0.52	0.52	0.49	0.33	0.33	-0.07
Total Current Assets	1.0	1.0	1.0	-0.82	-0.98	0.96	0.52	0.97	0.52	1.0	0.9	0.54		-0.31	0.84	0.94	0.94	0.94	0.96	0.71	0.71	-0.18
Short Term Debt	-0.31	-0.32	-0.34	0.18	0.19	-0.26	-0.21	-0.26	-0.21	-0.31	-0.18	0.46	-0.31		-0.08	-0.15	-0.3	-0.31	-0.21	-0.25	-0.25	0.23
Common Stock	0.82	0.82	0.87	-0.75	-0.86	0.68	0.78	0.72	0.78	0.86	0.86	0.75	0.84	-0.08		0.75	0.87	0.88	0.8	0.43	0.43	-0.19
Property Plant Equipment	0.94	0.94	0.93	-0.8	-0.97	0.94	0.3	0.96	0.3	0.94	0.89	0.48	0.94	-0.15	0.75		0.88	0.87	0.96	0.69	0.69	0.01
Net Invested Capital	0.93	0.94	0.95	-0.86	-0.93	0.86	0.48	0.88	0.48	0.94	0.97	0.52	0.94	-0.3	0.87	0.88		1.0	0.93	0.67	0.67	-0.19
Net Working Capital	0.93	0.94	0.95	-0.87	-0.92	0.86	0.5	0.88	0.5	0.94	0.96	0.52	0.94	-0.31	0.88	0.87	1.0		0.93	0.65	0.65	-0.22
Capital Stock	0.96	0.96	0.95	-0.84	-0.98	0.93	0.4	0.96	0.4	0.97	0.92	0.49	0.96	-0.21	0.8	0.96	0.93	0.93		0.69	0.69	-0.2
Accumulated Depreciation	0.74	0.73	0.69	-0.28	-0.66	0.83	0.22	0.81	0.22	0.7	0.73	0.33	0.71	-0.25	0.43	0.69	0.67	0.65	0.69		1.0	0.3
Current Deferred Revenue	0.74	0.73	0.69	-0.28	-0.66	0.83	0.22	0.81	0.22	0.7	0.73	0.33	0.71	-0.25	0.43	0.69	0.67	0.65	0.69	1.0		0.3
Long Term Investments	-0.15	-0.17	-0.18	0.47	0.15	-0.05	-0.26	-0.06	-0.26	-0.16	0.01	-0.07	-0.18	0.23	-0.19	0.01	-0.19	-0.22	-0.2	0.3	0.3

Click cells to compare fundamentals

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Competition

Predict Inspire Medical

Debt To Equity Over Time

Inspire Total Stockholder Equity

Total Stockholder Equity

601.14 Million

At this time, Inspire Medical's Total Stockholder Equity is relatively stable compared to the past year.

According to the company disclosure, Inspire Medical Systems has a Debt To Equity of 0.138%. This is 99.74% lower than that of the Health Care Technology sector and 99.66% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.72% higher than that of the company.

Inspire Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inspire Medical's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inspire Medical could also be used in its relative valuation, which is a method of valuing Inspire Medical by comparing valuation metrics of similar companies.

Inspire Medical is currently under evaluation in debt to equity category among its peers.

Inspire Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Inspire Medical from analyzing Inspire Medical's financial statements. These drivers represent accounts that assess Inspire Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inspire Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	1.8B	4.9B	6.3B	7.1B	6.0B	6.3B
Enterprise Value	1.8B	4.7B	6.1B	6.6B	5.8B	6.1B

Inspire Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inspire Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inspire Medical's managers, analysts, and investors.

Environmental

Governance

Social

Inspire Fundamentals

	Return On Equity	0.0533
	Return On Asset	0.0118
	Profit Margin	0.04 %
	Operating Margin	0.07 %
	Current Valuation	5.39 B
	Shares Outstanding	29.97 M
	Shares Owned By Insiders	1.94 %
	Shares Owned By Institutions	98.06 %
	Number Of Shares Shorted	2.24 M
	Price To Earning	15.29 X
	Price To Book	8.29 X
	Price To Sales	7.69 X
	Revenue	624.8 M
	Gross Profit	341.74 M
	EBITDA	(40.27 M)
	Net Income	(21.15 M)
	Cash And Equivalents	196.32 M
	Cash Per Share	7.10 X
	Total Debt	24.85 M
	Debt To Equity	0.14 %
	Current Ratio	5.62 X
	Book Value Per Share	23.25 X
	Cash Flow From Operations	24.65 M
	Short Ratio	4.10 X
	Earnings Per Share	1.12 X
	Price To Earnings To Growth	(2.57) X
	Target Price	239.6
	Number Of Employees	1.01 K
	Beta	1.36
	Market Capitalization	5.81 B
	Total Asset	676.81 M
	Retained Earnings	(345.42 M)
	Working Capital	515.63 M
	Current Asset	167.55 M
	Current Liabilities	64.84 M
	Net Asset	676.81 M

About Inspire Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Inspire Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inspire Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inspire Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Inspire Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Inspire Stock

0.61	DXCM	DexCom Inc Sell-off Trend	Pair Corr
0.59	LH	Laboratory	Pair Corr
0.55	VREX	Varex Imaging Corp	Pair Corr
0.47	GH	Guardant Health	Pair Corr
0.44	MD	Mednax Inc	Pair Corr

The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.

The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC